BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22673826)

  • 21. Moderate agreement between self-reported stroke and hospital-recorded stroke in two cohorts of Australian women: a validation study.
    Jackson CA; Mishra GD; Tooth L; Byles J; Dobson A
    BMC Med Res Methodol; 2015 Jan; 15():7. PubMed ID: 25613556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
    Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
    Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US.
    Tosteson AN; Do TP; Wade SW; Anthony MS; Downs RW
    Osteoporos Int; 2010 Oct; 21(10):1769-80. PubMed ID: 20101492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of osteoporosis risk assessment tools in middle-aged Thai women.
    Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Tanmahasamut P; Leerasiri P
    Climacteric; 2016 Dec; 19(6):588-593. PubMed ID: 27667093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.
    Eisman J; Clapham S; Kehoe L;
    J Bone Miner Res; 2004 Dec; 19(12):1969-75. PubMed ID: 15537439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
    Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
    Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Ban JK; Hao BB; McCarthy L; Guilcher SJT; Cadarette SM
    Osteoporos Int; 2019 Sep; 30(9):1865-1872. PubMed ID: 31317248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.
    Curtis JR; Westfall AO; Allison J; Freeman A; Kovac SH; Saag KG
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):710-8. PubMed ID: 16498575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hip fracture and other predictors of anti-osteoporosis drug use in Norway.
    Devold HM; Søgaard AJ; Tverdal A; Falch JA; Furu K; Meyer HE
    Osteoporos Int; 2013 Apr; 24(4):1225-33. PubMed ID: 22776863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis.
    Hopkins RB; Tarride JE; Leslie WD; Metge C; Lix LM; Morin S; Finlayson G; Azimaee M; Pullenayegum E; Goeree R; Adachi JD; Papaioannou A; Thabane L
    Osteoporos Int; 2013 Feb; 24(2):581-93. PubMed ID: 22572964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density.
    Salaffi F; Silveri F; Stancati A; Grassi W
    Clin Rheumatol; 2005 Jun; 24(3):203-11. PubMed ID: 15549501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.
    Genant HK; Jergas M; Palermo L; Nevitt M; Valentin RS; Black D; Cummings SR
    J Bone Miner Res; 1996 Jul; 11(7):984-96. PubMed ID: 8797120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of clinical prediction rules in detecting osteoporosis in a population-based sample of postmenopausal women.
    Mauck KF; Cuddihy MT; Atkinson EJ; Melton LJ
    Arch Intern Med; 2005 Mar; 165(5):530-6. PubMed ID: 15767529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity is not protective against fracture in postmenopausal women: GLOW.
    Compston JE; Watts NB; Chapurlat R; Cooper C; Boonen S; Greenspan S; Pfeilschifter J; Silverman S; Díez-Pérez A; Lindsay R; Saag KG; Netelenbos JC; Gehlbach S; Hooven FH; Flahive J; Adachi JD; Rossini M; Lacroix AZ; Roux C; Sambrook PN; Siris ES;
    Am J Med; 2011 Nov; 124(11):1043-50. PubMed ID: 22017783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication persistence in older women with osteoporosis: a pilot study.
    Gillette C; Howerton DM; Williams BD; Mahmood MA
    Osteoporos Int; 2015 Dec; 26(12):2883-8. PubMed ID: 26194492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can We Rely on Pharmacy Claims Databases to Ascertain Maternal Use of Medications during Pregnancy?
    Zhao JP; Sheehy O; Gorgui J; Bérard A
    Birth Defects Res; 2017 Apr; 109(6):423-431. PubMed ID: 28398706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.